Shraddha Parate

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 14

Top Topics

Chronic Myeloid Leukemia

Molecular Dynamics Simulations

Tyrosine Kinase

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Vikas Kumar, Raj Kumar, Shraddha Parate, null Danishuddin, Gihwan Lee, Moonhyuk Kwon, Seong-Hee Jeong, Hyeon-Su Ro, Keun Woo Lee, Seon-Won Kim
Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches. Biomolecules 13 (2) (2023)
Vikas Kumar, Raj Kumar, Shraddha Parate, null Danishuddin, Gihwan Lee, Moonhyuk Kwon, Seong-Hee Jeong, Hyeon-Su Ro, Keun Woo Lee, Seon-Won Kim
Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches. Biomolecules 13 (2) (2023)
Vikas Kumar, Raj Kumar, Shraddha Parate, null Danishuddin, Gihwan Lee, Moonhyuk Kwon, Seong-Hee Jeong, Hyeon-Su Ro, Keun Woo Lee, Seon-Won Kim
Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches. Biomolecules 13 (2) (2023)
Vikas Kumar, Raj Kumar, Shraddha Parate, null Danishuddin, Gihwan Lee, Moonhyuk Kwon, Seong-Hee Jeong, Hyeon-Su Ro, Keun Woo Lee, Seon-Won Kim
Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches. Biomolecules 13 (2) (2023)
Shraddha Parate, Vikas Kumar, Jong Chan Hong, Keun Woo Lee
Investigating natural compounds against oncogenic RET tyrosine kinase using pharmacoinformatic approaches for cancer therapeutics. RSC advances 12 (2) (2022)
Apoorva M Kulkarni, Vikas Kumar, Shraddha Parate, Gihwan Lee, Sanghwa Yoon, Keun Woo Lee
Identification of New KRAS G12D Inhibitors through Computer-Aided Drug Discovery Methods. International journal of molecular sciences 23 (3) (2022)
Apoorva M Kulkarni, Shraddha Parate, Gihwan Lee, Yongseong Kim, Tae Sung Jung, Keun Woo Lee, Min-Woo Ha
Computational Simulations Highlight the IL2Rα Binding Potential of Polyphenol Stilbenes from Fenugreek. Molecules (Basel, Switzerland) 27 (4) (2022)
Anu R Melge, Shraddha Parate, Keechilat Pavithran, Manzoor Koyakutty, Chethampadi G Mohan
Discovery of Anticancer Hybrid Molecules by Supervised Machine Learning Models and in Vitro Validation in Drug Resistant Chronic Myeloid Leukemia Cells. Journal of chemical information and modeling 62 (4) (2022)
Shraddha Parate, Vikas Kumar, Jong Chan Hong, Keun Woo Lee
Investigation of Marine-Derived Natural Products as Raf Kinase Inhibitory Protein (RKIP)-Binding Ligands. Marine drugs 19 (10) (2021)
Shraddha Parate, Vikas Kumar, Gihwan Lee, Shailima Rampogu, Jong Chan Hong, Keun Woo Lee
Marine-Derived Natural Products as ATP-Competitive mTOR Kinase Inhibitors for Cancer Therapeutics. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Shraddha Parate, Vikas Kumar, null Danishuddin, Jong Chan Hong, Keun Woo Lee
Computational Investigation Identified Potential Chemical Scaffolds for Heparanase as Anticancer Therapeutics. International journal of molecular sciences 22 (10) (2021)
Vikas Kumar, Shraddha Parate, Gunjan Thakur, Gihwan Lee, Hyeon-Su Ro, Yongseong Kim, Hong Ja Kim, Myeong Ok Kim, Keun Woo Lee
Identification of CDK7 Inhibitors from Natural Sources Using Pharmacoinformatics and Molecular Dynamics Simulations. Biomedicines 9 (9) (2021)
Shraddha Parate, Vikas Kumar, Jong Chan Hong, Keun Woo Lee
Identification of Flavonoids as Putative ROS-1 Kinase Inhibitors Using Pharmacophore Modeling for NSCLC Therapeutics. Molecules (Basel, Switzerland) 26 (8) (2021)
null Danishuddin, Vikas Kumar, Shraddha Parate, Ashutosh Bahuguna, Gihwan Lee, Myeong Ok Kim, Keun Woo Lee
Development of Machine Learning Models for Accurately Predicting and Ranking the Activity of Lead Molecules to Inhibit PRC2 Dependent Cancer. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)